Uterine artery embolization
Updates to Article Attributes
Uterine artery embolisation (UAE) is an interventional radiological technique to occludedecrease the arterial supply to the uterus and is performed for various reasons.
History
Uterine artery embolisation has been practised for more than 20 years for controlling post-partum haemorrhage following delivery/abortion, in .ectopic or cervical pregnancy, gestational trophoblastic disease or carcinoma of the cervix
The technique was first reported as an effective intervention for fibroids in 1995 when Ravinaet al noted that several women with symptomatic leiomyomata who underwent uterine artery embolisation as a pre-hysterectomy treatment had significant clinical improvement to an extent that hysterectomy was no longer required.
It is now estimated that more than 100,000 UAE procedures may have been performed so far for the treatment of fibroids.
Indications
-
intramuraluterine fibroids (intramural, submucosal, and subserosal)pelvic pain and pressure
symptoms/fullnessmass effect symptoms such as urinary frequency, bladder outlet obstruction and hydronephrosis due to ureteric compression
fibroids with otherwise undiagnosed infertility
as a preoperative
measure fortechnique to decrease the size of large fibroids
post-partum haemorrhage
-
other less common indications include
uterine AVM: trauma, post curettage
if active extravasation of contrast is detected during angiography for another reason (post-trauma)
Patients with fibroids, and their related problems, probably present the largest group who is most able to benefit from percutaneous treatmentuterine artery embolisation. Presently people with multiple and/or large symptomatic uterine fibroids traditionally undergo total abdominal, vaginal or laparoscopic-assisted hysterectomies around the world. The figure in the United States is about 60,000 hysterectomies per year. In less developed and more populous countries like India, the numbers may be even higher. There is an increasing need for non-invasive or less invasiveminimally alternatives for uterine fibroids and dysfunctional bleeding.
Contraindications
-
contraindications to angiography
uncorrectable coagulopathy
severe renal insufficiency
current pregnancy
active pelvic infection
prior pelvic radiationconnective tissue disease (relative)
prior surgery with adhesions (relative)
In addition, many international obstetrics practicegynaecology societal guidelines acknowledge that the effect of uterine artery embolisation (UAE) on pregnancy is understudied and thus currently do not recommend performing UAE on women who maintain a future desire for pregnancy. Exceptions to this may include women who have severe anaemia or symptoms associated with fibroids, have failed conservative measures and have contraindications to surgery or those who consent to UAE within an approved research protocol. However, recent studies have shown that fertility and miscarriage rates after uterine artery embolisation for fibroids are likely similar to the age-matched general population11.
Procedure
Preprocedural evaluation
a thorough
evaluation of patientsgynaecological history and examination covering the patient's symptoms and signsin consultation with a gynaecologistand goals of treatmentpelvic ultrasound and MRI
Pap smear andup-to-date cervical screeningconsider endometrial biopsy if there are concerning clinical or imaging features
relevant history of other medical problems
allergies
Equipment
Catheter selection
Any catheter suitable for contralateral and ipsilateral uterine artery cannulation
Robertson uterine catheter (RUC): commonly used selective catheter for pelvic angiography
Cobra glidecath: can also be used
right internal mammary catheter: may be used, but less common
If the above mentioned catheters are not available, bilateral common femoral artery puncture is an option for contralateral access to the uterine arteries.
Embolic agents
The type of embolic agent selected will depend on the indication.
-
embospheres (700 microns for fibroids, 500microns for adenomyosis)
-
postpartum haemorrhage or vaginal bleeding
gel foam slurry
coils (occasionally)
n-butyl-cyanoacrylate (glue)
Technique
The approach is dependent on operator preference.
Femoral access
The contralateral internal iliac artery is selected. The uterine artery is a branch of its anterior division and has a distinctive radiographic appearance. Care is taken to avoid cervical and vaginal branches, this is usually avoided by superselective catheterisation of the uterine artery distal to the origin of these branches.
The ipsilateral uterine artery is selected by formation of a waltman loop and subsequent embolisation performed.
Embolisation endpoint is stasis of the main uterine artery trunk.
The ovarian arteries may also be interrogated and if fibroid vascularity is detected these may also be embolised.
Brachial or radial access
This is performed via the left upper limb. In general, this technique allows for easier uterine artery selection, however, it presents challenges regarding catheter length and there is a theoretical, but small risk of stroke as the catheter crosses the origin of the left vertebral artery.
Peri-procedural care
patients are generally required to stay in hospital overnight to ensure adequate pain relief
-
analgesia
-
local anaesthesia
intra-arterial local anaesthetic injection has been described, but this has not achieved widespread acceptance ref
-
IV fluids
antiemetics
antibiotics
Intravenous fluids, analgesia, antiemetics and antibiotics need to be continued during the postprocedural period.
Complications
-
angiography complications
sepsis is a rare but serious complication and can be difficult to differentiate from post embolisation syndrome.
vaginal expulsion of fibroid tissue
premature onset menopause is uncommon but has been described in women over the age of 45 years
reproductive complications including increased risk of IUGR, PPH and PROM have been described in women who have undergone embolisation; it is unclear how much of this increased risk is attributable to the fibroids themselves or the embolisation procedure
Outcomes
For vaginal bleeding
alleviates need for emergency hysterectomy
resumption of menstruation
successful pregnancy after UAE for postpartum haemorrhage (PPH)
unsuspected abnormalities treated during UAE for PPH
For fibroids
menorrhagia/dysmenorrhoea and metrorrhagia improve in 70-95% of cases
hospital stay is rarely >48 hours
patients are often back to work within 10 days
no post laparotomy complications
mean uterine volume reduction by 26-59%
fibroid volume reduction by 40-75% (at the end of 6 months)
the overall complication rate is at ~10% with major complications at ~1.5%
In a recent study of two years following therapy, women with symptomatic uterine fibroids were shown to have mildly better health quality of life results with Myomectomy than uterine artery embolisation 10.
Current recommendations
American College of Obstetrics and Gynaecology (ACOG) in 2008 issued guidelines that patients with fibroids may be given an option of UAE 9
NICE (UK) in 2007 recommended UAE with surgery as a first-line treatment option
See also
-<p><strong>Uterine artery embolisation (UAE)</strong> is an interventional radiological technique to occlude the arterial supply to the <a href="/articles/uterus">uterus</a> and is performed for various reasons.</p><h4>History</h4><p>Uterine artery embolisation has been practised for more than 20 years for controlling haemorrhage following delivery/abortion, in <a href="/articles/ectopic-pregnancy">ectopic</a> or <a href="/articles/cervical-ectopic-pregnancy">cervical</a> pregnancy, <a href="/articles/gestational-trophoblastic-disease">gestational trophoblastic disease</a> or <a href="/articles/carcinoma-of-the-cervix">carcinoma of the cervix</a>.</p><p>The technique was first reported as an effective intervention for fibroids in 1995 when Ravina<em> </em>et al noted that several women with symptomatic leiomyomata who underwent uterine artery embolisation as a pre-hysterectomy treatment had significant clinical improvement to an extent that <a href="/articles/hysterectomy">hysterectomy</a> was no longer required.</p><p>It is now estimated that more than 100,000 UAE procedures may have been performed so far for the treatment of fibroids.</p><h4>Indications</h4><ul>- +<p><strong>Uterine artery embolisation (UAE)</strong> is an interventional radiological technique to decrease the arterial supply to the <a href="/articles/uterus">uterus</a> and is performed for various reasons.</p><h4>History</h4><p>Uterine artery embolisation has been practised for more than 20 years for controlling post-partum haemorrhage.</p><p>The technique was first reported as an effective intervention for fibroids in 1995 when Ravina<em> </em>et al noted that several women with symptomatic leiomyomata who underwent uterine artery embolisation as a pre-hysterectomy treatment had significant clinical improvement to an extent that <a href="/articles/hysterectomy">hysterectomy</a> was no longer required.</p><p>It is now estimated that more than 100,000 UAE procedures have been performed for the treatment of fibroids.</p><h4>Indications</h4><ul>
-<p>intramural <a href="/articles/uterine-leiomyoma">fibroids</a></p>- +<p>uterine <a href="/articles/uterine-leiomyoma">fibroids</a> (intramural, submucosal, and subserosal)</p>
-<li><p>pelvic pain and pressure symptoms</p></li>-<li><p><a href="/articles/bladder-outlet-obstruction">bladder outlet obstruction</a> and <a href="/articles/hydronephrosis">hydronephrosis</a> due to ureteric compression</p></li>- +<li><p>pelvic pain and pressure/fullness</p></li>
- +<li><p>mass effect symptoms such as urinary frequency, <a href="/articles/bladder-outlet-obstruction">bladder outlet obstruction</a> and <a href="/articles/hydronephrosis">hydronephrosis</a> due to ureteric compression</p></li>
-<li><p>as a preoperative measure for large fibroids</p></li>- +<li><p>as a preoperative technique to decrease the size of large fibroids</p></li>
- +<li><p>post-partum haemorrhage</p></li>
-</ul><p>Patients with fibroids, and their related problems, probably present the largest group who is most able to benefit from percutaneous treatment. Presently people with uterine fibroids traditionally undergo total abdominal, vaginal or laparoscopic-assisted hysterectomies around the world. The figure in the United States is about 60,000 hysterectomies per year. In less developed and more populous countries like India, the numbers may be even higher. There is an increasing need for non-invasive or less invasive alternatives for uterine fibroids and dysfunctional bleeding.</p><h4>Contraindications</h4><ul>- +</ul><p>Patients with fibroids, and their related problems, probably present the largest group who is most able to benefit from uterine artery embolisation. Presently people with multiple and/or large symptomatic uterine fibroids traditionally undergo total abdominal, vaginal or laparoscopic-assisted hysterectomies around the world. The figure in the United States is about 60,000 hysterectomies per year. In less developed and more populous countries like India, the numbers may be even higher. There is an increasing need for minimally alternatives for uterine fibroids and dysfunctional bleeding.</p><h4>Contraindications</h4><ul>
-<li><p>pregnancy</p></li>- +<li><p>current pregnancy</p></li>
-<li><p>prior pelvic radiation </p></li>-<li><p><a href="/articles/connective-tissue-disease-general">connective tissue disease</a></p></li>- +<li><p><a href="/articles/connective-tissue-disease-general">connective tissue disease</a> (relative)</p></li>
-</ul><p>In addition, many international obstetrics practice guidelines acknowledge that the effect of uterine artery embolisation (UAE) on pregnancy is understudied and thus currently do not recommend performing UAE on women who maintain a future desire for pregnancy. Exceptions to this may include women who have severe <a href="/articles/anaemia">anaemia</a> or symptoms associated with fibroids, have failed conservative measures and have contraindications to surgery or those who consent to UAE within an approved research protocol.</p><h4>Procedure</h4><h5>Preprocedural evaluation</h5><ul>-<li><p>a thorough evaluation of patients symptoms and signs in consultation with a gynaecologist </p></li>- +</ul><p>In addition, many gynaecology societal guidelines do not recommend performing UAE on women who maintain a future desire for pregnancy. Exceptions to this may include women who have severe <a href="/articles/anaemia">anaemia</a> or symptoms associated with fibroids, have failed conservative measures and have contraindications to surgery or those who consent to UAE within an approved research protocol. However, recent studies have shown that fertility and miscarriage rates after uterine artery embolisation for fibroids are likely similar to the age-matched general population<sup>11</sup>.</p><h4>Procedure</h4><h5>Preprocedural evaluation</h5><ul>
- +<li><p>a thorough gynaecological history and examination covering the patient's symptoms and signs and goals of treatment</p></li>
-<li><p>Pap smear and endometrial biopsy</p></li>- +<li><p>up-to-date cervical screening</p></li>
- +<li><p>consider endometrial biopsy if there are concerning clinical or imaging features</p></li>
References changed:
- 11. Mailli L, Patel S, Das R et al. Uterine Artery Embolisation: Fertility, Adenomyosis and Size - What is the Evidence? CVIR Endovasc. 2023;6(1):8. <a href="https://doi.org/10.1186/s42155-023-00353-2">doi:10.1186/s42155-023-00353-2</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/36847951">Pubmed</a>